In our cohort of AML-NK patients median expression level of ABCB1 gene was significantly lower compared to healthy controls (0.16, range 0.00–13.74 vs. 1.02, range 0.29–5.27, respectively) (P = 0.025). This evidence concerns the gene ABCB1 and acute myeloid leukemia.